News Search Results
Nov 17, 2025, 11:49 ET ANS abre consulta pública para decidir sobre a inclusão de novo medicamento para dermatite atópica
underestimated cytokine in atopic dermatitis. Allergy. 2020;75(1):54–62. doi:10.1111/all.13954 [21] Tsoi LC, et al. Atopic Dermatitis Is an IL-13-Dominant Disease with Greater Molecular Heterogeneity Compared to Psoriasis. J Invest Dermatol. 2019;139(7):1480-1489.
More news about: Eli Lilly do Brasil
Oct 24, 2025, 06:45 ET Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
Interleukin-13: Targeting an underestimated cytokine in atopic dermatitis. Allergy. 2020;75(1):54–62. doi:10.1111/all.13954. Tsoi LC, et al. Atopic Dermatitis Is an IL-13-Dominant Disease with Greater Molecular Heterogeneity Compared to Psoriasis. J Invest Dermatol. 2019;139(7):1480-1489.
More news about: Eli Lilly and Company
May 22, 2025, 07:38 ET CookUnity Launches in Canada With Top Chefs To Redefine Meal Delivery
Michelin-starred Chef Patrick Kriss of Alo Food Group, "Pad Ka Praow Beef with Thai Holy Basil" by Canadian Chef Sand Tsoi, a graduate from Cookin and one of the hand-picked chefs to launch Toronto's inaugural Smorgasburg market, "Jamaican
More news about: CookUnity
May 08, 2025, 22:00 ET Toys"R"Us Asia Luncurkan "Live Toyful": Era Baru yang Merayakan Semangat Bermain untuk Semua Kalangan Usia
Asia yang lebih dari sekadar toko mainan--kami mengubah semangat bermain sebagai bagian dari gaya hidup," ujar Leo Tsoi, CEO, Toys"R"Us Asia. "Perkembangan ini mencerminkan komitmen kami untuk menjadi unsur penting dalam kehidupan pelanggan sehari-hari, serta
More news about: Toys"R"Us Asia
Mar 21, 2025, 13:52 ET Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance
reducing hospital costs, and helping combat antimicrobial resistance. References: 1. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K,
More news about: Accelerate Diagnostics, Inc.
Mar 18, 2025, 12:26 ET bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance
select countries, followed by global launch starting in the second quarter of 2025. 1 Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet
More news about: bioMérieux
Mar 07, 2025, 08:30 ET Lilly's EBGLYSS® (lebrikizumab-lbkz) single monthly maintenance injection achieved completely clear skin at three years in half of patients with moderate-to-severe atopic dermatitis
T. Interleukin-13: Targeting an underestimated cytokine in atopic dermatitis. Allergy. 2020;75(1):54–62. doi:10.1111/all.139546 Tsoi LC, et al. Atopic Dermatitis Is an IL-13-Dominant Disease with Greater Molecular Heterogeneity Compared to Psoriasis. J Invest Dermatol. 2019;139(7):1480-1489.
More news about: Eli Lilly and Company